drugset / Trial / NCT02181972
Efficacy and Safety of Ginkgo Biloba in Middle-aged Cognitively Intact Adults
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objective of this study was to assess the efficacy and safety of Gingko biloba film-coated tablets in improving cognitive function and neuropsychological functioning of middle-aged cognitively intact adults.
Timeline
- Start
- 2002-05
- Primary completion
- 2002-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gingko Biloba | Unknown | 120 mg | Oral |
Indications
No indication recorded.